Operose Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Operose Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$2.46K	–	676
2026 Q1	$2.46K	Buy	+5	New	+$2.71K	﹤0.01%	484
2025 Q2	–	Sell	-16	Closed	-$7.96K	–	420
2025 Q1	$7.96K	Hold	16	–	–	﹤0.01%	335
2024 Q4	$8.32K	Sell	16 -75	-82%	-$41.2K	﹤0.01%	318
2024 Q3	$56.3K	Sell	91 -14	-13%	-$8.29K	0.02%	259
2024 Q2	$58.1K	Hold	105	–	–	0.02%	230
2024 Q1	$61K	Sell	105 -67	-39%	-$37.6K	0.02%	231
2023 Q4	$91.3K	Buy	172 +67	+64%	+$32.4K	0.04%	166
2023 Q3	$53.1K	Buy	105 +75	+250%	+$40K	0.02%	301
2023 Q2	$15.7K	Hold	30	–	–	0.01%	252
2023 Q1	$17.3K	Hold	30	–	–	0.01%	238
2022 Q4	$16.5K	Hold	30	–	–	0.01%	240
2022 Q3	$15K	Hold	30	–	–	0.01%	239
2022 Q2	$16K	Hold	30	–	–	0.01%	216
2022 Q1	$18K	Buy	+30	New	+$17.2K	0.01%	223

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Operose Advisors's TMO Position: Q2 2026 in Review

Operose Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 5 shares — an estimated $2.46K sold.

Operose Advisors first reported a position in TMO in Q1 2022 and held it in 14 quarters. The position peaked at $91.3K in Q4 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Operose Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Operose Advisors sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.46K.
Operose Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 14 quarters.
Operose Advisors's Thermo Fisher Scientific position peaked at $91.3K in Q4 2023.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.